Walker & Dunlop, Inc.
WD NYSE Finance Services Financials FY2016βFY2025
What Walker & Dunlop, Inc. does
No business description yet.
- Legal name
- Walker & Dunlop, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001104659-26-020249
0001497770
Revenue and margins
Walker & Dunlop, Inc. had $1.2B of revenue in fiscal 2025, up 9.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β8.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$680M in fiscal 2025, β55.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Walker & Dunlop, Inc. returned $102M to shareholders in fiscal 2025. The diluted share count rose 0.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Walker & Dunlop, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $306M | $226M | $329M | $279M | $299M |
| Total assets | $5.2B | $4.0B | $4.1B | $4.4B | $5.1B |
| Total liabilities | $3.6B | $2.3B | $2.3B | $2.6B | $3.3B |
| Shareholders' equity | $1.6B | $1.7B | $1.7B | $1.7B | $1.7B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β21.1% | β32.6% | 3.9% | β9.3% | 45.3% | β12.3% | β29.6% | 2.7% | β0.5% | 15.3% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $575M | $712M | $725M | $817M | $1.1B | $1.3B | $1.3B | $1.1B | $1.1B | $1.2B |
| Net interest income | β | β | β | β | β | $22.1M | $15.8M | β$5.6M | β$7.0M | β$5.5M |
| Provision for credit losses | β$0.6M | β$0.2M | $0.8M | $7.3M | $37.5M | β$13.3M | β$12.0M | β | β | β |
| Interest expense | $9.9M | $9.7M | $10.1M | $14.4M | $8.6M | $32.8M | $49.3M | $50.3M | $69.7M | $64.7M |
| Pretax income | $186M | $234M | $213M | $230M | $330M | $352M | $265M | $138M | $132M | $79.0M |
| Income tax | $71.5M | $21.8M | $51.9M | $57.1M | $84.3M | $86.4M | $56.0M | $35.0M | $30.5M | $22.0M |
| Net income | $114M | $211M | $161M | $173M | $246M | $266M | $214M | $107M | $108M | $56.2M |
| Net income to common | $109M | $203M | $156M | $168M | $239M | $257M | $208M | $105M | $106M | $54.9M |
| Diluted EPS | $3.57 | $6.47 | $4.96 | $5.45 | $7.69 | $8.15 | $6.36 | $3.18 | $3.19 | $1.64 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $759M | $1.1B | $64.1M | $428M | β$1.4B | $870M | $1.6B | β$0.5M | $129M | β$664M |
| Capital expenditure | $2.5M | $5.2M | $4.7M | $4.7M | $3.0M | $9.2M | $22.0M | $16.2M | $13.0M | $15.8M |
| Free cash flow | $757M | $1.1B | $59.4M | $423M | β$1.4B | $861M | $1.6B | β$16.7M | $116M | β$680M |
| Depreciation and amortization | $111M | $131M | $142M | $152M | $169M | $210M | $235M | $227M | $238M | $239M |
| Stock-based compensation | $18.5M | $21.1M | $24.0M | $24.1M | $28.3M | $36.6M | $34.0M | $27.8M | $27.3M | $26.7M |
| Share buybacks | $12.9M | $34.9M | $68.8M | $30.7M | $45.8M | $18.9M | $42.4M | $20.5M | $12.4M | $10.5M |
| Dividends paid | β | β | $31.4M | $37.3M | $45.4M | $64.5M | $80.1M | $84.8M | $88.6M | $91.8M |
| Dividends and buybacks | $12.9M | $34.9M | $100M | $67.9M | $91.1M | $83.3M | $123M | $105M | $101M | $102M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $119M | $191M | $90.1M | $121M | $321M | $306M | $226M | $329M | $279M | $299M |
| Loans, net | $220M | $66.5M | $497M | $544M | $360M | $269M | $200M | $40.1M | $32.9M | $77.8M |
| Property and equipment, net | β | β | β | β | β | $72.7M | $33.9M | $42.7M | $48.5M | $54.4M |
| Goodwill | $96.4M | $124M | $174M | $180M | $249M | $699M | $960M | $902M | $869M | $869M |
| Intangible assets | β | β | $670M | $719M | $1.9M | $184M | $199M | $182M | $157M | $142M |
| Total assets | $3.1B | $2.2B | $2.8B | $2.7B | $4.7B | $5.2B | $4.0B | $4.1B | $4.4B | $5.1B |
| Total liabilities | $2.4B | $1.4B | $1.9B | $1.6B | $3.5B | $3.6B | $2.3B | $2.3B | $2.6B | $3.3B |
| Shareholders' equity | $610M | $809M | $902M | $1.0B | $1.2B | $1.6B | $1.7B | $1.7B | $1.7B | $1.7B |
| Margins | ||||||||||
| Net margin | 19.8% | 29.7% | 22.3% | 21.2% | 22.7% | 21.1% | 17.0% | 10.2% | 9.6% | 4.6% |
| FCF margin | 131.6% | 149.2% | 8.2% | 51.7% | β130.5% | 68.4% | 124.0% | β1.6% | 10.3% | β55.1% |
| Net interest share of revenue | β | β | β | β | β | 1.8% | 1.3% | β0.5% | β0.6% | β0.4% |
| Returns | ||||||||||
| Return on equity | 18.7% | 29.7% | 18.9% | 17.9% | 22.1% | 19.4% | 13.2% | 6.3% | 6.2% | 3.2% |
| Return on assets | 3.7% | 8.0% | 6.5% | 6.4% | 6.7% | 5.4% | 4.6% | 2.7% | 2.6% | 1.2% |
| Return on tangible equity | 21.2% | 29.6% | 268.0% | 122.9% | 25.3% | 38.5% | 39.1% | 16.3% | 14.6% | 7.6% |
| Growth | ||||||||||
| Revenue growth | β | 23.7% | 1.9% | 12.7% | 32.6% | 16.2% | β0.0% | β16.2% | 7.4% | 9.0% |
| Net income growth | β | 85.4% | β23.5% | 7.4% | 42.0% | 8.0% | β19.5% | β49.8% | 0.8% | β48.0% |
| EPS growth | β | 81.2% | β23.3% | 9.9% | 41.1% | 6.0% | β22.0% | β50.0% | 0.3% | β48.6% |
| FCF growth | β | 40.4% | β94.4% | 612.4% | β434.5% | β | 81.2% | β101.1% | β | β684.3% |
| Share count change | β | 2.8% | β0.0% | β1.8% | 0.9% | 1.4% | 3.7% | 0.6% | 0.9% | 0.6% |
| Financial health | ||||||||||
| Provision / loans | β0.3% | β0.4% | 0.2% | 1.3% | 10.4% | β4.9% | β6.0% | β | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | 0.4% | 0.7% | 0.7% | 0.6% | 0.3% | 0.7% | 1.7% | 1.5% | 1.1% | 1.3% |
| Stock comp / revenue | 3.2% | 3.0% | 3.3% | 2.9% | 2.6% | 2.9% | 2.7% | 2.6% | 2.4% | 2.2% |
| Payouts / FCF | 1.7% | 3.3% | 168.9% | 16.1% | β | 9.7% | 7.8% | β | 86.8% | β |
| Quality scores | ||||||||||
| Accruals ratio | β21.1% | β32.6% | 3.9% | β9.3% | 45.3% | β12.3% | β29.6% | 2.7% | β0.5% | 15.3% |
Source: SEC EDGAR XBRL filings (CIK 0001497770). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.